Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Accesswire
*TORONTO, ON / ACCESSWIRE / May 10, 2024 /* Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused..
*TORONTO, ON / ACCESSWIRE / May 10, 2024 /* Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused..
*Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European..
Company to host a webcast today at 8:30 a.m. Eastern TimeNEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp...